Aurélie Ploquin
National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Viral Infections and Outbreaks Research, Viral Infections and Vectors, Virus-based gene therapy research, Hepatitis B Virus Studies, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody(2016)417 cited
- → Chimpanzee Adenovirus Vector Ebola Vaccine(2014)281 cited
- → Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial(2015)214 cited
- → Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study(2015)151 cited
- → Functional interrogation and mining of natively paired human VH:VL antibody repertoires(2018)140 cited
- → Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates(2021)104 cited
- → Protection Against Henipavirus Infection by Use of Recombinant Adeno-Associated Virus–Vector Vaccines(2012)103 cited
- → Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease(2021)97 cited
- → Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung(2021)82 cited
- → Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial(2023)62 cited